Current status of dynamic lymphoscintigraphy and sentinel lymph-node biopsy in urological malignancies

BJU International

Volumn 96, Issue 9, 2005, Pages 1235-1239

  Hadway, Paul ^a   Lynch, Mark ^a   Heenan, Susan ^a   Watkin, Nicholas A ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Lymphoscintigraphy; Sentinel lymph node; Urological malignancies

Indexed keywords

DISULFINE BLUE; TECHNETIUM 99M;

BLADDER CANCER; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DRUG HALF LIFE; HUMAN; KIDNEY CARCINOMA; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; PENIS CARCINOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SENTINEL LYMPH NODE BIOPSY; SHORT SURVEY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TESTIS CANCER; ULTRASOUND; URINARY TRACT CANCER;

HUMANS; LYMPHATIC METASTASIS; MALE; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN; UROGENITAL NEOPLASMS;

EID: 28544438557     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05738.x     Document Type: Short Survey

References (25)

1. Busch FM, Sayegh ES. Roentgenographic visualization of human testicular lymphatics: a preliminary report. J Urol 1963; 89: 106-10
2. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456-66
3. Wespes E, Simon J, Schulman CC. Cabanas approach: is sentinel node biopsy reliable for staging penile carcinoma? Urology 1986; 28: 278-9
4. Perinetti E, Crane DB, Catalona WJ. Unreliability of sentinel lymph node biopsy for staging penile carcinoma J Urol 1980; 124: 734-5
5. Pettaway CA, Pisters LL, Dinney CP et al. Sentinel lymph node dissection for penile carcinoma: The M.D. Anderson Cancer Center experience. J Urol 1995; 154: 1999-2003
6. Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early melanoma. Arch Surg 1992; 127: 392-9
7. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-401
8. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-9
9. Albertini JJ, Lyman GH, Cox C et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818-22
10. Horenblas S, Jansen L, Meinhardt W, Hoefnagel CA, de Jong D, Nieweg OE. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol 2000; 163: 100-4
11. Gershenwald JE, Colome MI, Lee JE et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998; 16: 2253-60
12. Kroon BK, Horenblas S, Estourgie SH et al. How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J Urol 2004; 171: 2191-4
13. Kroon BK, Horenblas S, Deurloo EE, Nieweg OE, Teertstra HJ. Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int 2005; 95: 517-21
14. Kroon BK, Lont AP, Valdes Olmos RA, Nieweg OE, Horenblas S. Morbidity of dynamic sentinel node biopsy in penile carcinoma. J Urol 2005; 173: 813-5
15. Kroon BK, Horenblas S, Lont AP, Tanis PJ, Gallee MP, Nieweg OE. Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol 2005; 173: 816-9
16. Ohyama C, Chiba Y, Yamazaki T, Endoh M, Hoshi S, Arai Y. Lymphatic mapping and gamma probe guided laparoscopic biopsy of sentinel lymph node in patients with clinical stage I testicular tumor. J Urol 2002; 168: 1390-5
17. Tanis PJ, Horenblas S, Valdes Olmos RA, Hoefnagel CA, Nieweg OE. Feasibility of sentinel node lymphoscintigraphy in stage I testicular cancer. Eur J Nucl Med Mol Imaging 2002; 29: 670-3
18. Poulsen AL, Horn T, Steven K. Radical cystectomy extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998; 160: 2015-9
19. Sherif A, De La Torre M, Malmstrom PU, Thorn M. Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J Urol 2001; 166: 812-5
20. Weckermann D, Wawroschek F, Harzmann R. Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy? Eur Urol 2005; 47: 45-50
21. Weingartner K, Ramaswamy A, Bittinger A, Gerharz EW, Voge D, Riedmiller H. Anatomical basis of pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 1996; 156: 1969-71
22. Wawroschek F, Vogt H, Weckermann D, Wagner T, Hamm M, Harzmann R. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 2001; 166: 1715-9
23. Rudoni M, Sacchetti GM, Leva L et al. Recent applications of the sentinel lymph node concept: preliminary experience in prostate cancer. Tumori 2002; 88: S16-7
24. Minervini A, Lilas L, Morelli G et al. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery? BJU Int 2001; 88: 169-72
25. Bernie JE, Zupkas P, Monga M. Intraoperative mapping of renal lymphatic drainage: technique and application in a porcine model. J Endourol 2003; 17: 235-7